In vivo angiogenesis imaging of solid tumors by αvβ 3-targeted, dual-modality micellar nanoprobes

Experimental Biology and Medicine

Volumn 235, Issue 8, 2010, Pages 957-965

  Kessinger, Chase W ^a   Khemtong, Chalermchai ^a   Togao, Osamu ^b   Takahashi, Masaya ^b   Sumer, Baran D ^a   Gao, Jinming ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

v 3 integrin; Cancer molecular imaging; Fluorescent polymeric micelles; Magnetic resonance imaging; Superparamagnetic iron oxide

Indexed keywords

COPOLYMER; NANOPARTICLE; TETRAMETHYLRHODAMINE; VITRONECTIN RECEPTOR; CYCLIC (ARGINYL-GLYCYL-ASPARTYL-PHENYLALANYL-LYSYL); CYCLOPEPTIDE; FLUORESCENT DYE; MAGNETITE; METAL NANOPARTICLE; MICELLE; POLYESTER; POLYLACTIDE; RHODAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMAGING; LIGHT SCATTERING; LUNG NON SMALL CELL CANCER; MICELLE; MOUSE; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SOLID TUMOR; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; DRUG SCREENING; HUMAN; LUNG TUMOR; MAGNETISM; METABOLISM; MOLECULAR IMAGING; NEOPLASM; NEOVASCULARIZATION, PATHOLOGIC; NUDE MOUSE; PROCEDURES; RADIATION SCATTERING; SYNTHESIS; VASCULARIZATION;

ANIMALS; FEMALE; FERROSOFERRIC OXIDE; FLUORESCENT DYES; HUMANS; INTEGRIN ALPHAVBETA3; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETICS; METAL NANOPARTICLES; MICE; MICE, NUDE; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES, CYCLIC; POLYESTERS; RHODAMINES; SCATTERING, RADIATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MUS;

EID: 77955677156     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010096     Document Type: Article

References (32)

1. Chandrachud LM, Pendleton N, Chisholm DM, Horan MA, Schor AM. Relationship between vascularity, age and survival in non-small-cell lung cancer. Br J Cancer 1997;76:1367-75 (Pubitemid 27474981)
2. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
3. O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007;96:189-95 (Pubitemid 46160619)
4. Mulder WJ, Strijkers GJ, Habets JW, Bleeker EJ, van der Schaft DW, Storm G, Koning GA, Griffioen AW, Nicolay K. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005;19:2008-10 (Pubitemid 41759747)
5. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 2003;49:403-8 (Pubitemid 36262806)
6. Sonvico F, Mornet S, Vasseur S, Dubernet C, Jaillard D, Degrouard J, Hoebeke J, Duguet E, Colombo P, Couvreur P. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem 2005;16:1181-8
7. Hogemann-Savellano D, Bos E, Blondet C, Sato F, Abe T, Josephson L, Weissleder R, Gaudet J, Sgroi D, Peters PJ, Basilion JP. The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia 2003;5:495-506 (Pubitemid 38045087)
8. Koole R, van Schooneveld MM, Hilhorst J, Castermans K, Cormode DP, Strijkers GJ, de Mello Donega C, Vanmaekelbergh D, Griffioen AW, Nicolay K, Fayad ZA, Meijerink A, Mulder WJ. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem 2008;19:2471-9
9. Zhang C, Jugold M, Woenne EC, Lammers T, Morgenstern B, Mueller MM, Zentgraf H, Bock M, Eisenhut M, Semmler W, Kiessling F. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 2007;67:1555-62 (Pubitemid 46383379)
10. Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J Nucl Med 2008;49(Suppl. 2):113S-28S
11. Khemtong C, Kessinger CW, Ren J, Bey EA, Yang SG, Guthi JS, Boothman DA, Sherry AD, Gao J. In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. Cancer Res 2009;69:1651-8
12. Cai W, Chen K, Mohamedali KA, Cao Q, Gambhir SS, Rosenblum MG, Chen X. PET of vascular endothelial growth factor receptor expression. J Nucl Med 2006;47:2048-56 (Pubitemid 47544993)
13. Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR, Gambhir SS, Chen X. Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. J Nucl Med 2006;47:113-21
14. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J Nucl Med 2004;45:1776-83
15. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994;264:569-71
16. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4
17. Meitar D, Crawford SE, Rademaker AW, Cohn SL. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol 1996;14:405-14 (Pubitemid 26051001)
18. Vosseler S, Mirancea N, Bohlen P, Mueller MM, Fusenig NE. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res 2005;65:1294-305 (Pubitemid 40270156)
19. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, Chin SF, Sherry AD, Boothman DA, Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006;6:2427-30
20. Luo L, Tam J, Maysinger D, Eisenberg A. Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles. Bioconjug Chem 2002;13:1259-65 (Pubitemid 35420018)
21. Sun S, Zeng H. Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc 2002;124:8204-5
22. Rader C, Popkov M, Neves JA, Barbas CF. Integrin alpha v beta 3-targeted therapy for Kaposi's sarcoma with an in vitro-evolved antibody. FASEB J 2002;16:2000-2
23. Nasongkla N, Shuai X, Ai H, Weinberg BD, Pink J, Boothman DA, Gao J. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl 2004;43:6323-7 (Pubitemid 40029462)
24. Schmieder AH, Caruthers SD, Zhang H, Williams TA, Robertson JD, Wickline SA, Lanza GM. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model. FASEB J 2008;22:4179-89
25. Ai H, Flask C, Weinberg B, Shuai X, Pagel MD, Farrell D, Duerk J, Gao JM. Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Adv Mater 2005;17:1949-52 (Pubitemid 41206143)
26. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53:283-318
27. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80 (Pubitemid 30660013)
28. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the keyb role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001;41:189-207 (Pubitemid 32520323)
29. Park JH, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl 2008;47:7284-8
30. Mills PH, Ahrens ET. Theoretical MRI contrast model for exogenous T2 agents. Magn Reson Med 2007;57:442-7
31. Ahrens ET, Rothbacher U, Jacobs RE, Fraser SE. A model for MRI contrast enhancement using T1 agents. Proc Natl Acad Sci USA 1998;95:8443-8 (Pubitemid 28350507)
32. Barcena C, Sra AK, Chaubey GS, Khemtong C, Liu JP, Gao J. Zinc ferrite nanoparticles as MRI contrast agents. Chem Commun (Camb) 2008;19:2224-6 (Pubitemid 351944588)